12 May 2014
Initiation
Overweight
Moelis
MC, MC US
Price: $27.55
We are recommending Moelis with an Overweight rating and 12/2014 price target
of $31. As a leading investment banking boutique, we believe Moelis is
positioned to take advantage of an improving M&A environment, one in which
boutiques are gaining market share as companies seek multiple advisors. Moelis
has a unique compensation structure that we feel better promotes internal growth
and reduces the potential that Moelis will stagnate and peak, as have many other
boutiques historically. We see earnings growth near term being driven by the
seasoning of its MDs and its expansion into new sectors and geographies.
M&A environment recovering. The M&A environment has been slowly
recovering since its recent trough in 2009. Total global deal value recovered to
$2.5tn in 2013 compared with 2009s level of $2.3tn, but it still remains well
below the peak of $4.6tn reached in 2007. Activity levels so far in 2014 are
amongst the strongest since 1995, which we view as a particular benefit to the
boutiques, which have been gaining deal market share, and to Moelis
particularly given its M&A focus with no trading or fixed income businesses.
AC
(1-212) 622-6613
kenneth.b.worthington@jpmorgan.com
Bloomberg JPMA WORTHINGTON <GO>
J.P. Morgan Securities LLC
Price Performance
32
30
$ 28
26
24
May-13
Aug-13
Nov-13
Feb-14
May-14
2013A
2014E
2015E
2016E
0.01
0.24
0.17
0.39
0.80
0.37A
0.26
0.37
0.56
1.56
0.38
0.30
0.40
0.68
1.77
0.40
0.30
0.43
0.74
1.88
Company Data
Price ($)
Date Of Price
52-week Range ($)
Market Cap ($ mn)
Fiscal Year End
Shares O/S (mn)
Price Target ($)
Price Target End Date
27.55
09 May 14
28.14-25.75
1,497.80
Dec
54
31.00
31-Dec-14
Table of Contents
Investment Thesis ....................................................................3
Risks to Rating and Price Target ............................................4
Company Description ..............................................................5
Moelis Business Overview ......................................................5
Financial Outlook ...................................................................20
Valuation .................................................................................20
Model .......................................................................................21
Investment Thesis
Moelis & Co. (MC)
Overweight
Moelis 2013 Revenue Mix
RE, Gmbl.,
Lodg.,&
Leisure,
12%
Healthcare,
6%
Cnsmr,
Retail &
Rest., 11%
Fin. Inst &
Gov't, 18%
Energy &
Power, 4%
Tech,
Media,
Telecom,
28%
Industrials,
21%
RE, Gmbl.,
Lodg.,& Leisure,
9%
Healthcare, 9%
Energy &
Power, 19%
Tech, Media,
Tele com, 18%
Industrials,
19%
the sharing of relationships and contacts as well as sector and banking knowledge
that helps drive better production out of the junior bankers over time.
Earnings Upside Comes from Expansion into New Geographies and Sectors
Earnings upside should result from the seasoning of the new MDs. Productivity
typically increases over time for MDs, which for Moelis has gone from an average of
$4mn in year 1 to $8mn by year 5. Having hired 200 junior bankers over the last
three years, and having brought on and promoted over 20 MDs over the last two
years, we see opportunity for upside. We model that productivity per banker/year
will rise from $5mn in 2013 to $6.4mn in 2016. This leads to projected revenue
increases over that time of $135mn on productivity alone.
Valuation Moelis Comes at a Discount, Offering Potential Upside vs Peers
As a new publicly traded company, we believe investors are valuing Moelis at a
discount to peers while they determine the aggressiveness/conservativeness of
revenue/expense guidance. If the companys compensation structure can drive higher
and more effective growth than expected over the interim, allowing the firm to grow
through the levels at which other boutiques over time have gotten capped. Then we
expect Moelis to go from trading at a discount to trading at a premium to peers.
Moelis currently trades at ~15.5x our 2015 EPS estimate of $1.77, a 3.4x discount to
the peer average. While growth projections are lower for Moelis than its peers, we
think conservative guidance (and therefore estimates) is the root cause. If the M&A
environment continues to improve, then Moelis could exceed estimates and
experience multiple expansion. We value Moelis at 17.5x our 2015 EPS estimate, a
small discount to where the peer group is trading. This brings us to a December
2014 price target of $31, representing upside of ~13% from its current stock price.
Company Description
Moelis & Company is a leading global independent investment bank that provides
innovative strategic and financial advice to a diverse client base, including
corporations, governments and financial sponsors. Moelis advises clients across all
major industry sectors and offers strategic solutions that include but are not limited to
mergers and acquisitions, restructuring and recapitalization, as well as corporate
finance. Moelis employs over 300 advisory professionals, which includes 80+
Managing Directors in 15 offices around the globe who have advised on over
$1 trillion of transactions since the companys inceptions in 2007. The company
became publicly traded in April 2014, and J.P. Morgan acted as a passive advisor.
Table 1: Moelis's Top Cross-Border Deals Demonstrate its Global Footprint and Diverse Industry
Expertise
Client
Deal Size
Transaction
Anheuser Busch
$61.2bn
Yahoo
$44.6bn
Natixis
30bn
Geographies
Omnicom Group
$35.1bn
American Airlines
$46.6bn
Heinz
$28bn
Hilton
$26.5bn
Gov't of Dubai
$24.9bn
Part of Moeliss success has been driven by its resources outside the US and its
ability to participate in cross-border transactions, which, as seen above, include many
of the larger transactions by deal size. Moelis has made significant investments in
expanding its global advisory footprint and currently advises clients in six regions
(North America, South America, Europe, Middle East, APAC, and China) where it
operates out of 15 offices.
Not surprisingly, Moelis has its biggest presence in North America, where it has six
offices, but sees greater advisory opportunities and attractive industry sectors in
Europe and Asia Pacific, where the company is looking to expand its presence. South
America/LATAM is another strategically important location for Moelis. With a lot of
advisory potential, especially within the commodities, utilities and energy sectors,
Moelis sees budding opportunities for its business there and has already initiated
efforts to establish a presence in the region.
Figure 1: Moeliss Global Footprint (No. of Offices)
%
North America
(6)
40%
Figures 2 and 3 support our view that activity levels and therefore Moeliss earnings
remain well below their potential based on industry activity levels seen both at peak
and at more normal levels. Figure 4 on the following page highlights M&A deal
7
value as a percent of 1-year trailing GDP, which is still well below the highs of 19992000 and 2006- 2007. All of this points to the assessment that deal value is still in the
earlier stages of a cyclical recovery, with meaningfully more room for greater
activity levels.
Figure 4: M&A Deal Value as a % of the 1-yr Trailing GDP, Shows that There Is Still a Lot of Room
for an M&A Recovery Back to Previous Highs
40.00%
35.00%
30.00%
25.00%
20.00%
15.00%
10.00%
5.00%
0.00%
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
M&A as % of 1yr Trailing GDP
Source, J.P. Morgan estimates, Dealogic Bloomberg.
700%
600%
500%
400%
300%
200%
100%
0%
M&A Total as a % of ECM Deal Value ($)
Based on current revenue at Moelis, were activity levels to return to peak levels and
remain there for a year, we estimate Moeliss revenue could grow 70%-80%, which
could lead to an incremental $1.10 of EPS in 2015.
Continued Activity in Recapitalization and Restructuring Market
We believe the restructuring business could also experience growth from current
levels as more frothy credit dynamics season. The amount of leverage, including
floating rate instruments, that companies have taken on in recent years could become
the catalyst for a more consistent recapitalization and restructuring market in the
coming years. As interest rates rise, credit markets could become more difficult to
access, even with an improving macroeconomic environment, increasing the need for
restructuring and recapitalization services. While restructuring has often been
countercyclical to traditional M&A, we see the potential for both Advisory and
Restructuring to potentially be strong at the same time.
Both 2012 and 2013 represented record years of leveraged finance issuance in the
U.S., as companies took advantage of historically low borrowing costs to leverage
their capital structures. We believe Moelis is well positioned to assist companies
8
through its holistic approach to providing solutions to clients in both robust and
challenging economic environments.
The Restructuring Business Provides a Strong Ballast to the Traditional
Advisory Business
The M&A business is particularly rewarding in periods of high deal activity, but is
typically cushioned in cycle downturns from strength in the restructuring business. In
times of economic uncertainty and weaker M&A activity, bankers often offer other
investment banking services like recapitalization and restructuring to companies
undergoing bankruptcy or which are in financial distress.
Moelis has done a good job in building out its restructuring business, in our view.
While the restructuring franchise has just a handful of truly dedicated bankers with
particularly focused technical expertise, Moelis has cross trained advisory bankers in
restructuring. According to data provided by Moelis, 2012 and 2013 represented two
of the biggest years of leverage finance issuance as companies took advantage of
lower borrowing costs to finance their capital expenditures. The fact that many
companies have taken on additional leverage in recent years due to historically low
interests rates provides some indication that activity will continue (as interest rates
rise or credit become tighter) in restructuring for Moelis over the next few years.
2009
2010
Strategic Advisory
2011
Restructuring
2012
2013
22
22
54
58
23
13
6
1
18
34
2008
2009
45
2010
US Advisory MDs
2011
2012
ROW Advisory MDs
63
2013
In Figure 11, which follows, we see that Moelis is adding MDs (now largely through
internal promotions) at a more rapid pace than at its leading boutique competitors.
We believe Moelis is well positioned to grow more quickly than other boutique peers
given its smaller size and its more rapidly expanding base of producing MDs. Here,
we note that Moelis has been growing MDs at a 35% CAGR compared with peer
growth between 0% and 15% annually
Figure 11: Moelis Is Showing Robust MD/SMD Headcount Growth Compared to Peers over 5 Yrs
160
151 151
140
120
100
86
80
66
60
40
20
0
70
52
34
19
Moelis MD
Headcount 5 Yr CGAR: 35%
Evercore SMD
Headcount 5-Yr
CAGR: 14%
2008
Greenhill MD
Headcount (5Yr CAGR: 6%)
Lazard MD
Headcount (5Yr CAGR: 0%)
2013
12
6%
4%
12% 11%
9%
9%
Industrials
18%
28%
21%
Industrials
15%
19%
19%
18%
Healthcare
RE, Gaming, Lodging &
Leisure
12%
Interestingly, Moelis has indicated that other banks have pulled back resources
overseas, leaving more opportunities for Moelis to win market share abroad. There
have been press reports about some of the larger banks like Barclays and RBS taking
steps over the last 18 months to further cut and/or scale back their global banking
operations. The sovereign debt crisis in Europe, along with political tensions in
EMEA, have forced the European banking sector to downsize operations in order to
rein in costs and increase capital buffers. The impacts of the latter provides smaller
firms like Moelis an opportunity to further penetrate and acquire greater share of the
European advisory market.
14
76
80
86
58
40
19
2008
2009
2010
2011
Total MDs
2012
2013
15
2012
2013
Moelis Revenue per MD
2014E
16
000s
000s
$14,000
$10,000
$9,000
$8,000
$7,000
$6,000
$5,000
$4,000
$3,000
$2,000
$1,000
$0
$12,000
$10,000
$8,000
$6,000
$4,000
$2,000
$0
2005
2006
2007
2008
2009
2010
2011
2012
2013
2005
2006
2007
2008
2009
2010
2011
2012
2013
utilizes a global rather than regional revenue pool for compensation distribution,
which enables Moelis to pay not only on banker production, but also on other criteria
to which management attributes high value. These attributes include collaboration,
global partnerships and training, which we feel translates into higher retention rates,
broader-based employee productivity and greater earnings growth over time.
Moelis Compensation System The Structure
Moelis employs a discretionary payout model driven by various performance/
evaluation criteria. The compensation process entails frequent sit-downs (typically
every six months) with management. These reviews drive transparency, which
management feels is an effective way to manage banker expectations and banker
behavior.
The compensation structure is formulated off equity and cash payouts no different
than most investment banks. However, what is different is that there is a material
clawback for cash compensation. Here, any cash bonus paid to an MD who ends up
leaving within a 12-month period is required to be paid back in full to Moelis, with
clawback step-downs occurring as the vesting process continues over the subsequent
12 months. The clawback is based on non-compete clauses in MD contracts that are
triggered when Moelis employees leave for competitors. Other compensation awards
are largely RSUs that are designed to reward and retain talented employees, which
Moelis believes are essential to the companys long-term growth and overall success.
Moelis has built in some flexibility in its comp structure by providing a mix of equity
and cash bonuses. The proportion varies from banker to banker depending on
milestones, goals as well as the circumstances of each individual employee. Equity
payouts are one of the compensation features that enable Moelis to incentivize its
employees and align banker interests with the equity holders.
Table 2: Moeliss Cash Bonus Vesting Schedule
%
For this development program to work, it needs buy-in from the senior bankers in the
firm to share their contacts, promote junior banker relationships and forest junior
banker growth. These are sometimes low priority for senior bankers, but given the
discretion and leverage Ken Moelis and management have in determining
compensation, they influence behavior by rewarding those who contribute to
building the culture and developing junior bankers. Given the clawback on cash
earnings, the possibility of having compensation withheld for 1-2 years while the
past bonus vests becomes a very powerful motivator.
A flatter compensation structure ties production more to pay across the pool of
bankers, allowing Moelis to retain and develop internal talent more successfully.
This is in contrast to larger firms with contracts for most of the senior bankers,
resulting in less compensation for the juniors. Moeliss compensation structure
increases the chances that not only do more junior bankers grow to become senior
bankers over time, but also that both the junior and senior bankers are retained,
allowing Moelis to get a better return on its banker investment.
Moelis Compensation Structure Promoting the Fluid Business Model
We believe Moelis is well positioned to execute on multiple fronts within its
flourishing advisory business. Were branding this as the Fluid Business Model,
which we think ultimately allows for greater efficiency from both a personnel
perspective as well as from a client-service perspective. Ultimately, it would appear
that the Fluid Business Model drives more business for Moelis.
By implementing a fluid business model, Moeliss bankers are able to more easily
cross over from different advisory projects that could range from traditional M&A to
more specialized risk solutions or restructurings. With advisory projects cyclical, the
cross-training of bankers in both advisory and restructuring, for example, allows
broader servicing of the customer. Furthermore, it allows for greater efficiency for
the investment bank, with bankers better able to toggle between various services
rather than succumbing to the boom and bust cycles of the advisory business.
Management expects that it has a more collaborative culture, given the more
distributive revenue structure across bankers, sectors and geographies. Overall,
Moelis prides itself on the fact that its senior bankers (i.e., MDs) are multifaceted
professionals who are capable of executing on technical matters as well as
strategically engaging clients and bringing in new business. Management estimates
that out of roughly 80+ global MDs, nearly all are providing both advisory and
restructuring services to their clients.
Moeliss Compensation Structure Retaining the Banker, and Getting Compensation
When They Leave
From managements point of view, one of the most appealing features of the
compensation structure is that it essentially discourages bankers from leaving before
they are fully vested. Employee contracts contain clauses that permit management to
defer large portions of awarded compensation, which makes it financially difficult
for bankers to pursue external opportunities. The fact that competitors would have to
make up the unvested portion of the bonus makes Moeliss employees more
expensive to hire than their counterparts at other banks. This structure helps Moelis
combat poaching and permits the company to make greater investments in its people
without worrying about recouping losses related to the exodus of intellectual capital.
19
But when they do leave, Moelis gets a big check, helping to ease the loss of high
producing bankers.
Financial Outlook
We are modeling EPS of $1.56 in 2013, $1.77 in 2014 and $1.88 in 2015. Our
revenue is generated on a production level per banking MD, which we have rising
from $5.0mn/MD in 2013 to $5.7mn in 2014, $6.1mn in 2015, and $6.4mn in 2016.
We have the base of MDs growing from 86 in 2013 to 89 in 2014, 93 in 2015 and 97
in 2016. We expect margins to remain ~28%, and model a corporate tax rate of 40%.
We model shares outstanding of 55.3mn shares.
Valuation
As a new publicly traded company, we feel Moelis we believe investors are valuing
MC at a discount to peers while they determine the aggressiveness/conservativeness
of revenue/expense guidance. If we are right that the compensation structure can
drive higher and more effective growth over the intermediate term, and allow the
firm to grow through the levels at which other boutiques over time have gotten
capped, then we think Moelis could go from trading at a discount to trading at a
premium to peers. Moelis trades at 15.6x our 2015 EPS estimate of $1.77, a ~3x
discount to peers. While growth projections are lower for Moelis than for peers, we
think conservative Moelis guidance is the root cause. If the M&A environment
continues to improve, then Moelis could exceed estimates at a time when its
valuation could rise, offering investors a much higher stock price. We value Moelis
at 17.5x our 2015 EPS estimate, a slight discount to where the peer group is trading
due to lower projected growth based on what we view as conservative expectations.
This brings us to a December 2014 price target of $31, representing upside of
~12.5% from its current stock price.
Table 3: Comparables for Evercore, Greenhill and Lazard
Price
Company Name
JPM
Market
EPS Estimate
Price to EPS:
Cap.
MC
$26.73
OW
$1,496
$0.42
$0.80
$1.56
$1.77
34.4x
17.7x
15.6x
EVR
$55.38
NA
$2,215
$1.78
$2.25
$2.44
$3.13
24.4x
22.5x
17.6x
Greenhill
GHL
$51.07
NA
$1,424
$1.38
$1.55
$1.60
$2.25
32.5x
31.5x
22.4x
Lazard
LAZ
$49.36
NA
$6,329
$1.44
$2.01
$2.76
$3.24
24.3x
17.7x
15.1x
27.1x
23.9x
18.4x
Average
Source: J.P. Morgan estimates for Moelis, Bloomberg for all other estimates.
20
Models
Table 44: Moelis & Co.s Earnings Model
Adj. Diluted EPS
2012
2013
0.42 $
0.80 $
2014E
1.56 $
2015E
1.77 $
2016E
1.88 $
1Q12
(0.01) $
2Q12
0.06 $
3Q12
0.06 $
4Q12
0.31 $
1Q13
0.01 $
2Q13
0.24 $
3Q13
0.17 $
4Q13
0.39 $
1Q14
0.37 $
2Q14E
0.26 $
3Q14E
0.37 $
4Q14E
0.56 $
1Q15E
0.38 $
2Q15E
0.30 $
3Q15E
0.40 $
4Q15E
0.68 $
1Q16E
0.40 $
2Q16E
0.30 $
3Q16E
0.43 $
4Q16E
0.74
Revenues
Revenue
385,900
411,300
496,167
556,737
610,215
65,700
93,800
100,100
126,300
59,800
98,500
98,700
154,300
114,517
92,400
122,375
166,875
125,006
104,052
137,765
189,914
137,122
114,084
150,977
208,033
Total Revenue
385,900
411,300
496,167
556,737
610,215
65,700
93,800
100,100
126,300
59,800
98,500
98,700
154,300
114,517
92,400
122,375
166,875
125,006
104,052
137,765
189,914
137,122
114,084
150,977
208,033
105,663
71,622
13,225
84,847
95,531
23,691
119,222
99,085
25,972
125,057
23,562
4,158
27,720
23,863
4,895
28,758
24,197
4,172
28,369
23,751
8,750
32,501
23,932
4,682
28,614
24,109
5,511
29,619
23,739
4,748
28,487
24,682
9,599
34,281
24,528
5,134
29,662
24,911
6,039
30,950
24,964
5,201
30,165
159,281
100,888
47,692
(29,325)
119,255
138,478
72,376
(24,720)
186,133
154,140
79,328
(13,320)
220,148
14,784
15,708
(9,775)
20,717
30,986
15,297
(9,775)
36,508
55,117
16,688
(9,775)
62,030
28,751
16,251
(6,180)
38,822
22,892
13,527
(6,180)
30,238
36,508
17,909
(6,180)
48,237
50,327
24,689
(6,180)
68,836
31,538
17,826
(3,330)
46,034
25,669
14,831
(3,330)
37,170
40,764
19,627
(3,330)
57,061
56,169
27,044
(3,330)
79,883
Expenses
Compensation Expense
Salary
Benefits, Payroll Tax
Salary, Benefits, Payroll Tax
11,825
8,285
8,285
7,400
2,225
2,200
2,071
2,071
2,071
2,071
2,071
2,071
2,071
2,071
275,000
71.3%
265,000
64.4%
276,019
56%
313,641
56%
353,490
58%
49,600
75.5%
70,800
75.5%
75,600
75.5%
79,000
62.5%
43,600
72.9%
58,400
59.3%
65,000
65.9%
98,000
63.5%
60,092
52%
55,837
60%
67,491
55%
92,599
55%
73,395
59%
60,924
59%
79,928
58%
99,394
52%
82,386
60%
68,903
60%
90,082
60%
112,119
54%
Pre-IPO Backout
Adjusted Compensation Expense
% of Revenue
275,000
71.3%
265,000
64.4%
11,825
264,194
53%
8,285
305,356
55%
8,285
345,205
57%
49,600
75.5%
70,800
75.5%
75,600
75.5%
79,000
62.5%
43,600
72.9%
58,400
59.3%
65,000
65.9%
98,000
63.5%
60,092
52%
7,400
48,437
52%
2,225
65,266
53%
2,200
90,399
54%
2,071
71,323
57%
2,071
58,853
57%
2,071
77,856
57%
2,071
97,323
51%
2,071
80,314
59%
2,071
66,832
59%
2,071
88,011
58%
2,071
110,048
53%
269,838
69.9%
257,752
62.7%
292,355
59%
334,042
60%
366,129
60%
59,549
0%
56,364
61%
74,649
61%
101,794
61%
75,003
60%
62,431
60%
82,659
60%
113,948
60%
82,273
60%
68,450
60%
90,586
60%
124,820
60%
72,800
76,300
92,106
96,334
102,429
17,000
16,900
17,800
21,100
17,000
17,400
19,200
22,700
20,141
20,790
24,475
26,700
20,001
19,250
24,798
32,285
21,940
21,106
26,098
33,285
347,800
341,300
356,300
401,689
447,633
66,600
87,700
93,400
100,100
60,600
75,800
84,200
120,700
80,233
69,227
89,741
117,099
91,324
78,102
102,654
129,609
102,254
87,937
114,109
143,333
38,100
9.87%
70,000
17.02%
139,867
28.19%
155,047
27.85%
162,582
26.64%
-900
0.00%
6,100
0.00%
6,700
0.00%
26,200
0.00%
(800)
0.00%
22,700
0.00%
14,500
0.00%
33,600
0.00%
34,284
0.00%
23,173
25.08%
32,634
26.67%
49,776
29.83%
33,681
26.94%
25,950
24.94%
35,111
25.49%
60,306
31.75%
34,868
25.43%
26,147
22.92%
36,867
24.42%
64,700
31.10%
(600)
300
3,600
(800)
3,540
19
8,205
-
10,380
-
0
-100
-900
100
-1,200
100
1,500
200
1,400
100
-600
0
1,700
-1,100
1,100
200
(1,220)
19
1,150
-
1,530
-
2,080
-
1,815
-
1,540
-
2,040
-
2,810
-
2,300
-
1,950
-
2,580
-
3,550
-
37,800
(15,120)
40%
72,800
(29,120)
40%
143,426
(57,370)
40%
163,252
(65,301)
40%
172,962
(69,184)
40%
-1,000
400
40.0%
5,300
(2,120)
40.0%
5,600
(2,240)
40.0%
27,900
(11,160)
40.0%
700
(280)
40.0%
22,100
(8,840)
40.0%
15,100
(6,040)
40.0%
34,900
(13,960)
40.0%
33,083
(13,233)
40.0%
24,323
(9,729)
40.0%
34,164
(13,665)
40.0%
51,856
(20,743)
40.0%
35,496
(14,198)
40.0%
27,490
(10,996)
40.0%
37,151
(14,860)
40.0%
63,116
(25,246)
40.0%
37,168
(14,867)
40.0%
28,097
(11,239)
40.0%
39,447
(15,779)
40.0%
68,250
(27,300)
40.0%
22,680
43,680
86,056
97,951
103,778
(600)
3,180
3,360
16,740
420
13,260
9,060
20,940
19,850
14,594
20,498
31,114
21,298
16,494
22,290
37,869
22,301
16,858
23,668
40,950
54,366
54,366
55,098
55,341
55,341
54,366
54,366
54,366
54,366
54,366
54,366
54,366
54,366
54,366
55,341
55,341
55,341
55,341
55,341
55,341
55,341
55,341
55,341
55,341
55,341
21
Balance Sheet
(Dollars in thousands)
Period
Assets
Cash And Cash Equivalents
Investments At Fair Value
Total Cash (Excluding Restricted Cash)
Restricted Cash
Total Cash (Including Restricted Cash)
Receivables:
Accounts Receivable
Interest And Dividends Receivable
Other Receivables
Total Receivables
2012
2013
$26,331 $153,943
139,138
68,141
$165,469 $222,084
160,066
149,873
$325,535 $371,957
$37,541
351
9,299
$47,191
$28,784
39
6,520
$35,343
Deferred Compensation
Investment In Equity-Method
Equipment And Leasehold Improvements
Intangible Assets
Deferred Tax Asset
Prepaid Expenses And Other Assets
Total Assets
$6,314
$3,495
10,371
12,481
5,786
5,156
211
42
1,682
1,315
3,570
13,674
$400,660 $443,463
$120,204 $103,928
8,842
14,262
2,649
6,838
6,045
8,466
$137,740 $133,494
Equity
Total Equity
Total liabilities and equity
$262,920 $309,969
$400,660 $443,463
check
22
(276)
140
0
143
(57)
86
86
55
1.56
1.56
(314)
155
0
163
(65)
98
98
55
1.77
1.77
(353)
163
0
173
(69)
104
104
55
1.88
1.88
154
407
443
Total debt
Total liabilities
Preferred stockholders' equity
Common stockholders' equity
133
310
Net income
D&A
Capex
Free cash flow
FCF / share
1Q14A
(60)A
34A
0A
33A
(13)A
20A
20A
54A
0.37A
0.37A
(56)
23
0
24
(10)
15
15
55
0.26
0.26
(67)
33
0
34
(14)
20
20
55
0.37
0.37
(93)
50
0
52
(21)
31
31
55
0.56
0.56
Ratio Analysis
FY13A
FY14E
FY15E
FY16E
Revenue growth
EPS growth
92.6%
94.4%
13.3%
5.9%
Tax rate
Net income margin
40.0%
-
40.0%
-
40.0%
-
40.0%
-
15.2%
-
55.5%
-
23
Analyst Certification: The research analyst(s) denoted by an AC on the cover of this report certifies (or, where multiple research
analysts are primarily responsible for this report, the research analyst denoted by an AC on the cover or within the document
individually certifies, with respect to each security or issuer that the research analyst covers in this research) that: (1) all of the views
expressed in this report accurately reflect his or her personal views about any and all of the subject securities or issuers; and (2) no part of
any of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views
expressed by the research analyst(s) in this report. For all Korea-based research analysts listed on the front cover, they also certify, as per
KOFIA requirements, that their analysis was made in good faith and that the views reflect their own opinion, without undue influence or
intervention.
Important Disclosures
Lead or Co-manager: J.P. Morgan acted as lead or co-manager in a public offering of equity and/or debt securities for Moelis within
the past 12 months.
Client: J.P. Morgan currently has, or had within the past 12 months, the following company(ies) as clients: Moelis.
Investment Banking (past 12 months): J.P. Morgan received in the past 12 months compensation from investment banking Moelis.
Client/Investment Banking: J.P. Morgan currently has, or had within the past 12 months, the following company(ies) as investment
banking clients: Moelis.
Investment Banking (next 3 months): J.P. Morgan expects to receive, or intends to seek, compensation for investment banking
services in the next three months from Moelis.
Company-Specific Disclosures: Important disclosures, including price charts, are available for compendium reports and all J.P. Morgan
covered companies by visiting https://jpmm.com/research/disclosures, calling 1-800-477-0406, or e-mailing
research.disclosure.inquiries@jpmorgan.com with your request. J.P. Morgans Strategy, Technical, and Quantitative Research teams may
screen companies not covered by J.P. Morgan. For important disclosures for these companies, please call 1-800-477-0406 or e-mail
research.disclosure.inquiries@jpmorgan.com.
Moelis (MC, MC US) Price Chart
42
35
28
Price($)
21
14
0
Apr
14
Apr
14
Apr
14
May
14
May
14
May
14
Source: Bloomberg and J.P. Morgan; price data adjusted for stock splits and dividends.
The chart(s) show J.P. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire
period.
J.P. Morgan ratings or designations: OW = Overweight, N= Neutral, UW = Underweight, NR = Not Rated
Explanation of Equity Research Ratings, Designations and Analyst(s) Coverage Universe:
J.P. Morgan uses the following rating system: Overweight [Over the next six to twelve months, we expect this stock will outperform the
average total return of the stocks in the analysts (or the analysts teams) coverage universe.] Neutral [Over the next six to twelve
months, we expect this stock will perform in line with the average total return of the stocks in the analysts (or the analysts teams)
coverage universe.] Underweight [Over the next six to twelve months, we expect this stock will underperform the average total return of
the stocks in the analysts (or the analysts teams) coverage universe.] Not Rated (NR): J.P. Morgan has removed the rating and, if
24
applicable, the price target, for this stock because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy
reasons. The previous rating and, if applicable, the price target, no longer should be relied upon. An NR designation is not a
recommendation or a rating. In our Asia (ex-Australia) and U.K. small- and mid-cap equity research, each stocks expected total return is
compared to the expected total return of a benchmark country market index, not to those analysts coverage universe. If it does not appear
in the Important Disclosures section of this report, the certifying analysts coverage universe can be found on J.P. Morgans research
website, www.jpmorganmarkets.com.
Coverage Universe: Worthington, Kenneth B: Apollo Global Management (APO), BM&F Bovespa (BVMF3.SA), BlackRock (BLK),
CBOE Holdings (CBOE), CME Group Inc. (CME), Charles Schwab (SCHW), Eaton Vance Corp (EV), Evercore Partners Inc. (EVR),
FXCM (FXCM), Federated Investors, Inc. (FII), Franklin Resources (BEN), Invesco Ltd. (IVZ), Investment Technology Group (ITG),
Janus Capital Group (JNS), KCG Holdings (KCG), LPL Financial Holdings Inc. (LPLA), Manning & Napier (MN), Nasdaq OMX
(NDAQ), Oaktree Capital Group, LLC (OAK), Och-Ziff Capital Management (OZM), Pzena Investment Management (PZN), T. Rowe
Price Group, Inc (TROW), The Carlyle Group (CG), The Intercontinental Exchange (ICE)
J.P. Morgan Equity Research Ratings Distribution, as of March 31, 2014
Overweight
(buy)
44%
58%
45%
78%
Neutral
(hold)
44%
49%
48%
67%
Underweight
(sell)
11%
40%
7%
60%
Equity Valuation and Risks: For valuation methodology and risks associated with covered companies or price targets for covered
companies, please see the most recent company-specific research report at http://www.jpmorganmarkets.com, contact the primary analyst
or your J.P. Morgan representative, or email research.disclosure.inquiries@jpmorgan.com.
Equity Analysts' Compensation: The equity research analysts responsible for the preparation of this report receive compensation based
upon various factors, including the quality and accuracy of research, client feedback, competitive factors, and overall firm revenues.
Other Disclosures
J.P. Morgan ("JPM") is the global brand name for J.P. Morgan Securities LLC ("JPMS") and its affiliates worldwide. J.P. Morgan Cazenove is a marketing
name for the U.K. investment banking businesses and EMEA cash equities and equity research businesses of JPMorgan Chase & Co. and its subsidiaries.
All research reports made available to clients are simultaneously available on our client website, J.P. Morgan Markets. Not all research content is
redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your sales
representative.
Options related research: If the information contained herein regards options related research, such information is available only to persons who have
received the proper option risk disclosure documents. For a copy of the Option Clearing Corporation's Characteristics and Risks of Standardized Options,
please contact your J.P. Morgan Representative or visit the OCC's website at http://www.optionsclearing.com/publications/risks/riskstoc.pdf
Legal Entities Disclosures
U.S.: JPMS is a member of NYSE, FINRA, SIPC and the NFA. JPMorgan Chase Bank, N.A. is a member of FDIC. U.K.: JPMorgan Chase N.A., London
Branch, is authorised by the Prudential Regulation Authority and is subject to regulation by the Financial Conduct Authority and to limited regulation by
the Prudential Regulation Authority. Details about the extent of our regulation by the Prudential Regulation Authority are available from J.P. Morgan on
request. J.P. Morgan Securities plc (JPMS plc) is a member of the London Stock Exchange and is authorised by the Prudential Regulation Authority and
regulated by the Financial Conduct Authority and the Prudential Regulation Authority. Registered in England & Wales No. 2711006. Registered Office 25
Bank Street, London, E14 5JP. South Africa: J.P. Morgan Equities South Africa Proprietary Limited is a member of the Johannesburg Securities
Exchange and is regulated by the Financial Services Board. Hong Kong: J.P. Morgan Securities (Asia Pacific) Limited (CE number AAJ321) is regulated
by the Hong Kong Monetary Authority and the Securities and Futures Commission in Hong Kong and/or J.P. Morgan Broking (Hong Kong) Limited (CE
number AAB027) is regulated by the Securities and Futures Commission in Hong Kong. Korea: J.P. Morgan Securities (Far East) Ltd, Seoul Branch, is
regulated by the Korea Financial Supervisory Service. Australia: J.P. Morgan Australia Limited (JPMAL) (ABN 52 002 888 011/AFS Licence No:
238188) is regulated by ASIC and J.P. Morgan Securities Australia Limited (JPMSAL) (ABN 61 003 245 234/AFS Licence No: 238066) is regulated by
ASIC and is a Market, Clearing and Settlement Participant of ASX Limited and CHI-X. Taiwan: J.P.Morgan Securities (Taiwan) Limited is a participant
of the Taiwan Stock Exchange (company-type) and regulated by the Taiwan Securities and Futures Bureau. India: J.P. Morgan India Private Limited,
having its registered office at J.P. Morgan Tower, Off. C.S.T. Road, Kalina, Santacruz East, Mumbai - 400098, is a member of the National Stock
Exchange of India Limited (SEBI Registration Number - INB 230675231/INF 230675231/INE 230675231) and Bombay Stock Exchange Limited (SEBI
Registration Number - INB 010675237/INF 010675237) and is regulated by Securities and Exchange Board of India. For non local research reports, this
material is not distributed in India by J.P. Morgan India Private Limited. Thailand: This material is issued and distributed in Thailand by JPMorgan
25
Securities (Thailand) Ltd., which is a member of the Stock Exchange of Thailand and is regulated by the Ministry of Finance and the Securities and
Exchange Commission and its registered address is 3rd Floor, 20 North Sathorn Road, Silom, Bangrak, Bangkok 10500. Indonesia: PT J.P. Morgan
Securities Indonesia is a member of the Indonesia Stock Exchange and is regulated by the OJK a.k.a. BAPEPAM LK. Philippines: J.P. Morgan Securities
Philippines Inc. is a Trading Participant of the Philippine Stock Exchange and a member of the Securities Clearing Corporation of the Philippines and the
Securities Investor Protection Fund. It is regulated by the Securities and Exchange Commission. Brazil: Banco J.P. Morgan S.A. is regulated by the
Comissao de Valores Mobiliarios (CVM) and by the Central Bank of Brazil. Mexico: J.P. Morgan Casa de Bolsa, S.A. de C.V., J.P. Morgan Grupo
Financiero is a member of the Mexican Stock Exchange and authorized to act as a broker dealer by the National Banking and Securities Exchange
Commission. Singapore: This material is issued and distributed in Singapore by or through J.P. Morgan Securities Singapore Private Limited (JPMSS)
[MCI (P) 199/03/2014 and Co. Reg. No.: 199405335R] which is a member of the Singapore Exchange Securities Trading Limited and is regulated by the
Monetary Authority of Singapore (MAS) and/or JPMorgan Chase Bank, N.A., Singapore branch (JPMCB Singapore) which is regulated by the MAS. This
material is provided in Singapore only to accredited investors, expert investors and institutional investors, as defined in Section 4A of the Securities and
Futures Act, Cap. 289. Recipients of this document are to contact JPMSS or JPMCB Singapore in respect of any matters arising from, or in connection
with, the document. Japan: JPMorgan Securities Japan Co., Ltd. is regulated by the Financial Services Agency in Japan. Malaysia: This material is issued
and distributed in Malaysia by JPMorgan Securities (Malaysia) Sdn Bhd (18146-X) which is a Participating Organization of Bursa Malaysia Berhad and a
holder of Capital Markets Services License issued by the Securities Commission in Malaysia. Pakistan: J. P. Morgan Pakistan Broking (Pvt.) Ltd is a
member of the Karachi Stock Exchange and regulated by the Securities and Exchange Commission of Pakistan. Saudi Arabia: J.P. Morgan Saudi Arabia
Ltd. is authorized by the Capital Market Authority of the Kingdom of Saudi Arabia (CMA) to carry out dealing as an agent, arranging, advising and
custody, with respect to securities business under licence number 35-07079 and its registered address is at 8th Floor, Al-Faisaliyah Tower, King Fahad
Road, P.O. Box 51907, Riyadh 11553, Kingdom of Saudi Arabia. Dubai: JPMorgan Chase Bank, N.A., Dubai Branch is regulated by the Dubai Financial
Services Authority (DFSA) and its registered address is Dubai International Financial Centre - Building 3, Level 7, PO Box 506551, Dubai, UAE.
Country and Region Specific Disclosures
U.K. and European Economic Area (EEA): Unless specified to the contrary, issued and approved for distribution in the U.K. and the EEA by JPMS plc.
Investment research issued by JPMS plc has been prepared in accordance with JPMS plc's policies for managing conflicts of interest arising as a result of
publication and distribution of investment research. Many European regulators require a firm to establish, implement and maintain such a policy. This
report has been issued in the U.K. only to persons of a kind described in Article 19 (5), 38, 47 and 49 of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005 (all such persons being referred to as "relevant persons"). This document must not be acted on or relied on by persons
who are not relevant persons. Any investment or investment activity to which this document relates is only available to relevant persons and will be
engaged in only with relevant persons. In other EEA countries, the report has been issued to persons regarded as professional investors (or equivalent) in
their home jurisdiction. Australia: This material is issued and distributed by JPMSAL in Australia to "wholesale clients" only. This material does not take
into account the specific investment objectives, financial situation or particular needs of the recipient. The recipient of this material must not distribute it to
any third party or outside Australia without the prior written consent of JPMSAL. For the purposes of this paragraph the term "wholesale client" has the
meaning given in section 761G of the Corporations Act 2001. Germany: This material is distributed in Germany by J.P. Morgan Securities plc, Frankfurt
Branch and J.P.Morgan Chase Bank, N.A., Frankfurt Branch which are regulated by the Bundesanstalt fr Finanzdienstleistungsaufsicht. Hong Kong: The
1% ownership disclosure as of the previous month end satisfies the requirements under Paragraph 16.5(a) of the Hong Kong Code of Conduct for Persons
Licensed by or Registered with the Securities and Futures Commission. (For research published within the first ten days of the month, the disclosure may
be based on the month end data from two months prior.) J.P. Morgan Broking (Hong Kong) Limited is the liquidity provider/market maker for derivative
warrants, callable bull bear contracts and stock options listed on the Stock Exchange of Hong Kong Limited. An updated list can be found on HKEx
website: http://www.hkex.com.hk. Japan: There is a risk that a loss may occur due to a change in the price of the shares in the case of share trading, and
that a loss may occur due to the exchange rate in the case of foreign share trading. In the case of share trading, JPMorgan Securities Japan Co., Ltd., will be
receiving a brokerage fee and consumption tax (shouhizei) calculated by multiplying the executed price by the commission rate which was individually
agreed between JPMorgan Securities Japan Co., Ltd., and the customer in advance. Financial Instruments Firms: JPMorgan Securities Japan Co., Ltd.,
Kanto Local Finance Bureau (kinsho) No. 82 Participating Association / Japan Securities Dealers Association, The Financial Futures Association of Japan,
Type II Financial Instruments Firms Association and Japan Investment Advisers Association. Korea: This report may have been edited or contributed to
from time to time by affiliates of J.P. Morgan Securities (Far East) Ltd, Seoul Branch. Singapore: JPMSS and/or its affiliates may have a holding in any of
the securities discussed in this report; for securities where the holding is 1% or greater, the specific holding is disclosed in the Important Disclosures
section above. India: For private circulation only, not for sale. Pakistan: For private circulation only, not for sale. New Zealand: This material is issued
and distributed by JPMSAL in New Zealand only to persons whose principal business is the investment of money or who, in the course of and for the
purposes of their business, habitually invest money. JPMSAL does not issue or distribute this material to members of "the public" as determined in
accordance with section 3 of the Securities Act 1978. The recipient of this material must not distribute it to any third party or outside New Zealand without
the prior written consent of JPMSAL. Canada: The information contained herein is not, and under no circumstances is to be construed as, a prospectus, an
advertisement, a public offering, an offer to sell securities described herein, or solicitation of an offer to buy securities described herein, in Canada or any
province or territory thereof. Any offer or sale of the securities described herein in Canada will be made only under an exemption from the requirements to
file a prospectus with the relevant Canadian securities regulators and only by a dealer properly registered under applicable securities laws or, alternatively,
pursuant to an exemption from the dealer registration requirement in the relevant province or territory of Canada in which such offer or sale is made. The
information contained herein is under no circumstances to be construed as investment advice in any province or territory of Canada and is not tailored to
the needs of the recipient. To the extent that the information contained herein references securities of an issuer incorporated, formed or created under the
laws of Canada or a province or territory of Canada, any trades in such securities must be conducted through a dealer registered in Canada. No securities
commission or similar regulatory authority in Canada has reviewed or in any way passed judgment upon these materials, the information contained herein
or the merits of the securities described herein, and any representation to the contrary is an offence. Dubai: This report has been issued to persons regarded
as professional clients as defined under the DFSA rules. Brazil: Ombudsman J.P. Morgan: 0800-7700847 / ouvidoria.jp.morgan@jpmorgan.com.
General: Additional information is available upon request. Information has been obtained from sources believed to be reliable but JPMorgan Chase & Co.
or its affiliates and/or subsidiaries (collectively J.P. Morgan) do not warrant its completeness or accuracy except with respect to any disclosures relative to
JPMS and/or its affiliates and the analyst's involvement with the issuer that is the subject of the research. All pricing is as of the close of market for the
securities discussed, unless otherwise stated. Opinions and estimates constitute our judgment as of the date of this material and are subject to change
without notice. Past performance is not indicative of future results. This material is not intended as an offer or solicitation for the purchase or sale of any
financial instrument. The opinions and recommendations herein do not take into account individual client circumstances, objectives, or needs and are not
26
intended as recommendations of particular securities, financial instruments or strategies to particular clients. The recipient of this report must make its own
independent decisions regarding any securities or financial instruments mentioned herein. JPMS distributes in the U.S. research published by non-U.S.
affiliates and accepts responsibility for its contents. Periodic updates may be provided on companies/industries based on company specific developments or
announcements, market conditions or any other publicly available information. Clients should contact analysts and execute transactions through a J.P.
Morgan subsidiary or affiliate in their home jurisdiction unless governing law permits otherwise.
"Other Disclosures" last revised April 5, 2014.
Copyright 2014 JPMorgan Chase & Co. All rights reserved. This report or any portion hereof may not be reprinted, sold or
redistributed without the written consent of J.P. Morgan. #$J&098$#*P
27